# Bioheng

**Canonical:** https://apis.io/providers/bioheng/  
**Website:** https://www.imvivabio.com  
**APIs profiled:** 1

Bioheng, operating under the brand Imviva, is a clinical-stage biotechnology company focused on developing allogeneic CAR‑T cell therapies for oncology and autoimmune diseases. The company aims to create scalable, off‑the‑shelf cell therapies to broaden patient access and advance regenerative medicine.

## Kin Score — 4.3 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 4.3).

| Facet | Score |
|---|---|
| Discoverability | 53.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Bioheng API** — Imviva provides an API platform but no machine‑readable contract was discovered. The website lists product information but no developer documentation or OpenAPI spec is publicly...

## Security (1)

- **Bioheng Domain Security** — TLSv1.3 · HSTS

## Tags

Biotechnology, Cell Therapy, Oncology, Autoimmune Disease, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bioheng/). Scores are computed from the provider's own public artifacts under a published rubric.